The Patent Finder

Nucleic Acids and Methods for Detecting Chromosomal Abnormalities

Biora Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,465,245Nucleic Acids and Methods for Detecting Chromosomal Abnormalities
In force
 · High confidence
UsedRemaining
Biora Therapeutics, Inc.In forceHigh confidence
US 10,947,595Nucleic Acids and Methods for Detecting Chromosomal Abnormalities
Lapsed Mar 16, 2025 on the fee record
Low confidence
Biora Therapeutics, Inc.Lapsed Mar 16, 2025 on the fee recordLow confidence
Application 16/596,118Nucleic Acids and Methods for Detecting Chromosomal Abnormalities
Abandoned
Abandoned Feb 22, 2024
Biora Therapeutics, Inc.AbandonedAbandoned Feb 22, 2024
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Biora Therapeutics, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited